Covestor’s ProPhase Labs PRPH Stock Holding History

Covestor’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-502	Closed	-$36K	–	2578
2023 Q2	$36K	Buy	502 +192	+62%	+$15.6K	0.03%	919
2023 Q1	$24K	Sell	310 -13	-4%	-$1.05K	0.02%	944
2022 Q4	$31K	Sell	323 -9	-3%	-$972	0.03%	902
2022 Q3	$37K	Buy	+332	New	+$38.6K	0.03%	812

Other funds holding PRPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Covestor's PRPH Position: Q3 2023 in Review

Covestor sold out of ProPhase Labs (PRPH) in Q3 2023, closing a stake of 502 shares — an estimated $36K sold.

Covestor first reported a position in PRPH in Q3 2022 and held it in 4 quarters. The position peaked at $37K in Q3 2022. 35 funds tracked by Wall St. Rank hold PRPH as of Q3 2023.

Covestor reported no remaining ProPhase Labs position as of Q3 2023 after selling out during the quarter.
Covestor sold 502 ProPhase Labs shares in Q3 2023, an estimated $36K.
Covestor first reported a position in ProPhase Labs in Q3 2022 and held it in 4 quarters.
Covestor's ProPhase Labs position peaked at $37K in Q3 2022.
35 funds tracked by Wall St. Rank held ProPhase Labs as of Q3 2023.

Based on Covestor's 13F filing for Q3 2023, filed 13 Nov 2023.